• Aucun résultat trouvé

Immune responses during COVID-19 infection

N/A
N/A
Protected

Academic year: 2021

Partager "Immune responses during COVID-19 infection"

Copied!
25
0
0

Texte intégral

Loading

Figure

Figure 1. Natural history of COVID-19 infection, from incubation to critical disease. Incubation phase is reported as variable between 0-14 days, 3,5  then first clinical symptoms,  upper  respiratory  tract  infection  (URTI)  (rhinitis,  anosmia  and  ag
Figure 2. Extrapulmonary manifestations of COVID-19 identified in severe and critically ill patients (percentage in hospitalized patients)
Figure  3. Putative  immune  scenarios  associated  with  protective  immune  responses
Figure 5. Race between viral replication and immune responses during viral infection with SARS-CoV viruses

Références

Documents relatifs

Recently, however, reports from Europe and North America have described clusters of children and adolescents requiring admission to intensive care units with a multisystem

The systemic inflammatory response syndrome (SIRS) is the body response to injury or insult, infectious or non-infectious condition characterized by a hyperinflammatory state.. SIRS

Based upon these previous data, the aim of the present study was to evaluate whether serum soluble TWEAK could be a reliable biomarker of neuroinflammation in MS patients. We

expression, we FACS purified eYFP + and eYFP – CD4 T cells from draining lymph node and spinal cord of MOG-CFA immunized mice and stimulated the cells in the presence of..

To understand the underlying molecular differences in host response, primary chicken and duck lung cells, infected with two HPAI H5N1 viruses and a low pathogenicity avian

MPs, microparticles; EMPs, endothelial cells derived microparticles; PMPs, platelets derived microparticles; HD, healthy donors; SSc, systemic sclerosis; MTX, methotrexate;

Les deux dernières sont généralement basées sur une réaction de dérivatisation de l'histamine avec l'orthophthalaldéhyde (OPA). L'inconvénient majeur du dérivé

The HLA-B, HLA-C and KIR genetic profiles were deter- mined from 162 individuals divided into four groups as follows: Group 1 - individuals infected with HIV-1 and